Literature DB >> 29203989

Strategies for Differentiating Gallbladder Carcinoma from Xanthogranulomatous Cholecystitis-a Tertiary Care Centre Experience.

Rajaguru Kishore1, Samiran Nundy1, Siddharth Mehrotra1, Naimish Metha1, Vivek Mangla1, Shailendra Lalwani1.   

Abstract

Xanthogranulomatous cholecystitis (XGC) is an uncommon variant of chronic cholecystitis, characterized by focal or diffuse destructive inflammatory process. The importance of XGC is that it mimics gallbladder carcinoma (GBC) both preoperatively and intra-operatively, since it can present with pericholecystic infiltration, hepatic involvement and lymphadenopathy. As a result of this misdiagnosis which is not infrequent, the patient may need to undergo an unnecessary radical cholecystectomy rather than only a cholecystectomy which is associated with greater morbidity and mortality. Patients who underwent gallbladder and gallbladder-related operations during period of 5 years between 2010 and 2014 were reviewed (n = 462). A comparison of clinical, biochemical, radiological and operative features were made between patients with carcinoma gallbladder (n = 101) and xanthogranulomatous cholecystitis (n = 22). Patient with a long history of recurrent abdominal pain with leucocytosis and who on imaging are found to have a diffusely thickened gallbladder wall (p < 0.01), with cholelithiasis, choledocholithiasis and sub-mucosal hypoattenuated nodules (p < 0.05) are likely to have XGC while those with anorexia, weight loss, focal thickening of the gallbladder wall on imaging (p < 0.01) and dense local organ infiltration are more likely to have GBC. The presence of lymph nodes on imaging and the loss of fat plane interface between the liver and gallbladder are not differentiating factors. Differentiating XGC from GBC in preoperative setting is necessary to avoid radical procedures being done for a benign process. Certain clinical, radiological and intra-operative features aid in differentiating these benign and malignant process. However, the definitive diagnosis still remains a histopathological examination to avoid radical resection in patients who have a benign condition.

Entities:  

Keywords:  Carcinoma gallbladder; Radical cholecystectomy; Sub-mucosal nodules; Xanthogranulomatous cholecystitis

Year:  2017        PMID: 29203989      PMCID: PMC5705511          DOI: 10.1007/s13193-017-0677-7

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  29 in total

1.  Should laparoscopic cholecystectomy be performed in patients with thick-walled gallbladder?

Authors:  Gadiyaram Srikanth; Ashok Kumar; Ritu Khare; Lakshmaiah Siddappa; Archana Gupta; Sadiq Saleem Sikora; Rajan Saxena; Vinay Kumar Kapoor
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004

2.  US findings of xanthogranulomatous cholecystitis.

Authors:  P N Kim; H K Ha; Y H Kim; M G Lee; M H Kim; Y H Auh
Journal:  Clin Radiol       Date:  1998-04       Impact factor: 2.350

3.  Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.

Authors:  T W Kang; S H Kim; H J Park; S Lim; K M Jang; D Choi; S J Lee
Journal:  Clin Radiol       Date:  2013-04-25       Impact factor: 2.350

4.  Xanthogranulomatous cholecystitis.

Authors:  V K Dixit; A Prakash; A Gupta; M Pandey; A Gautam; M Kumar; V K Shukla
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer.

Authors:  Ling-Fu Zhang; Chun-Sheng Hou; Jian-Yu Liu; Dian-Rong Xiu; Zhi Xu; Li-Xin Wang; Xiao-Feng Ling
Journal:  Chin Med J (Engl)       Date:  2012-01       Impact factor: 2.628

6.  Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.

Authors:  R V Raghavendra Rao; Ashok Kumar; Sadiq S Sikora; Rajan Saxena; Vinay K Kapoor
Journal:  Trop Gastroenterol       Date:  2005 Jan-Mar

7.  Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis.

Authors:  Antonio Rodríguez-Fernández; Manuel Gómez-Río; José Manuel Llamas-Elvira; Simeón Ortega-Lozano; Jose Antonio Ferrón-Orihuela; Jose Manuel Ramia-Angel; Alfonso Mansilla-Roselló; María Dolores Martínez-del-Valle; Carlos Ramos-Font
Journal:  Am J Surg       Date:  2004-08       Impact factor: 2.565

8.  Simultaneous xanthogranulomatous cholecystitis and primary adenocarcinoma of gallbladder.

Authors:  E W Benbow; P M Taylor
Journal:  Histopathology       Date:  1988-06       Impact factor: 5.087

9.  Xanthogranulomatous cholecystitis.

Authors:  J P Houston; M C Collins; I Cameron; M W Reed; M A Parsons; K M Roberts
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

10.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

Authors:  Christopher D Anderson; Michael H Rice; C Wright Pinson; William C Chapman; Ravi S Chari; Dominique Delbeke
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

View more
  2 in total

1.  Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening.

Authors:  Vikas Gupta; K S Vishnu; Thakur D Yadav; Yashwant R Sakaray; Santosh Irrinki; B R Mittal; N Kalra; K Vaiphei
Journal:  J Gastrointest Cancer       Date:  2019-12

2.  Xanthogranulomatous Cholecystitis with Coexisting Carcinoma- A Diagnostic Pitfall in Cytology.

Authors:  Anupama Arya; Shaily Goyal; Dilip Kumar; Poonam Das
Journal:  J Cytol       Date:  2022-05-20       Impact factor: 1.577

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.